Small Animal Imaging
小动物成像
基本信息
- 批准号:7491891
- 负责人:
- 金额:$ 15.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-23 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AnatomyAnesthesia proceduresAnimal ModelAnimalsArtsBedsBiologicalCellsConsultationsContrast MediaCoupledData SetDetectionEvaluationGasesHybridsImageIsofluraneManufacturer NameMethodologyMissionModalityPhysiologic MonitoringProteinsRadiochemistryRadiolabeledRangeRattusResearchResearch PersonnelResolutionRodentScanningScheduleSystemTechnologydetectorin vivoinnovationmemberradiotracerreconstructionsmall moleculetumor
项目摘要
The UWCCC Small Animal Imaging Facility provides innovative, state-of-the-art, affordable, noninvasive,
high-resolution in-vivo and ex-vivo imaging support to UWCCC members who utilize small animal models in
their research. The facility director and manager provide consultation with investigators about
methodologies most suited to answer their biological questions. Investigators are able to select various
levels of support ranging from image acquisition alone, to acquisition and reconstruction, to image
interpretation and finally to media presentation. Because of their radiochemistry expertise, they also
radiolabel small molecules or proteins for investigators prior to imaging.
Anatomic MicroCT Scanning. A MicroCAT-2 from Siemens/CTI is equipped with a large field-of-view
detector, thus allowing high resolution scanning (18 micron)'of rats up to 300 grams. The system is equipped
with a rodent isoflurane gas anesthesia system and physiologic monitoring system which allows image
gating,
Functional MicroPET Scanning. Functional microPET imaging is also available. Because both scanners
are from the same manufacturer, the scanning beds are completely interchangeable which allows scanning
with both modalities without moving the animal, thus allowing fairly accurate fusion of the two data sets.
We are scheduled to acquire the first commercial microCT/microPET hybrid scanner from Siemens/CTI in
June of 2006. This world's first hybrid scanner coupled with our own proprietary cell-selective imaging and
contrast agents affords our investigators unique tumor detection and evaluation technologies which can only
be provided here.
UWCCC小动物成像设备提供创新的,最先进的,价格合理的,无创的,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMEY P WEICHERT其他文献
JAMEY P WEICHERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMEY P WEICHERT', 18)}}的其他基金
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10024889 - 财政年份:2020
- 资助金额:
$ 15.17万 - 项目类别:
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
用于剂量测定引导免疫调节的新型分子靶向放射性核素疗法
- 批准号:
10263245 - 财政年份:2020
- 资助金额:
$ 15.17万 - 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10416049 - 财政年份:2020
- 资助金额:
$ 15.17万 - 项目类别:
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
用于剂量测定引导免疫调节的新型分子靶向放射性核素疗法
- 批准号:
10416045 - 财政年份:2020
- 资助金额:
$ 15.17万 - 项目类别:
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
用于剂量测定引导免疫调节的新型分子靶向放射性核素疗法
- 批准号:
10672913 - 财政年份:2020
- 资助金额:
$ 15.17万 - 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10672952 - 财政年份:2020
- 资助金额:
$ 15.17万 - 项目类别:
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
用于剂量测定引导免疫调节的新型分子靶向放射性核素疗法
- 批准号:
10024881 - 财政年份:2020
- 资助金额:
$ 15.17万 - 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10263250 - 财政年份:2020
- 资助金额:
$ 15.17万 - 项目类别:
IMTEK MICROCAT II MICROCT SCANNER: BREAST, PANCREATIC, & THYROID CANCER
IMTEK MICROCAT II 微型 CT 扫描仪:乳房、胰腺、
- 批准号:
7166483 - 财政年份:2005
- 资助金额:
$ 15.17万 - 项目类别: